Lipopolysaccharides From Non-Helicobacter pylori Gastric Bacteria Potently Stimulate Interleukin-8 Production in Gastric Epithelial Cells.


Journal

Clinical and translational gastroenterology
ISSN: 2155-384X
Titre abrégé: Clin Transl Gastroenterol
Pays: United States
ID NLM: 101532142

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 27 3 2019
medline: 22 5 2020
entrez: 27 3 2019
Statut: ppublish

Résumé

Gastric acid secretion is compromised in chronic Helicobacter pylori (H. pylori) infection allowing overgrowth of non-H. pylori gastric bacteria (NHGB) in the stomach. NHGB were isolated from gastric mucosa in selective media and further characterized with biochemical methods and 16S rRNA gene sequencing. Human gastric tissues were studied with indirect immunofluorescence with antibodies against H. pylori and Neisseria subflava (N. subflava). Gastric epithelial cell lines were cocultured with bacteria or incubated with lipopolysaccharides isolated from NHGB, and interleukin-8 released in the media was measured by enzyme-linked immunosorbent assay. Expression of Toll-like receptor (TLR)2, TLR4, it's coreceptor myeloid differentiation factor 2 (MD2), and CD14 in gastric cells was investigated by immunofluorescence microscopy and reverse transcriptase-polymerase chain reaction. Haemophilus species, Neisseria species, Fusobacterium species, and Veillonella species were predominant Gram-negative bacteria coinfected with H. pylori. Lipopolysaccharides from N. subflava potently stimulated interleukin-8 secretion in MKN45 cells which was cancelled by preincubation with polymyxin B. TLR2, TLR4, CD14, and myeloid differentiation factor 2 were expressed in MKN45 cells, though their levels of expression were low. N. subflava adhered to MKN45 cells in vitro and colocalized with H. pylori in the human gastric mucosa. Our data suggest that N. subflava colonized in the gastric mucosa contribute to gastric inflammation during chronic H. pylori gastritis. NHGB may perpetuate gastric inflammation and accelerate neoplastic progression in the hypochlorhydric stomach.

Sections du résumé

BACKGROUND
Gastric acid secretion is compromised in chronic Helicobacter pylori (H. pylori) infection allowing overgrowth of non-H. pylori gastric bacteria (NHGB) in the stomach.
METHODS
NHGB were isolated from gastric mucosa in selective media and further characterized with biochemical methods and 16S rRNA gene sequencing. Human gastric tissues were studied with indirect immunofluorescence with antibodies against H. pylori and Neisseria subflava (N. subflava). Gastric epithelial cell lines were cocultured with bacteria or incubated with lipopolysaccharides isolated from NHGB, and interleukin-8 released in the media was measured by enzyme-linked immunosorbent assay. Expression of Toll-like receptor (TLR)2, TLR4, it's coreceptor myeloid differentiation factor 2 (MD2), and CD14 in gastric cells was investigated by immunofluorescence microscopy and reverse transcriptase-polymerase chain reaction.
RESULTS
Haemophilus species, Neisseria species, Fusobacterium species, and Veillonella species were predominant Gram-negative bacteria coinfected with H. pylori. Lipopolysaccharides from N. subflava potently stimulated interleukin-8 secretion in MKN45 cells which was cancelled by preincubation with polymyxin B. TLR2, TLR4, CD14, and myeloid differentiation factor 2 were expressed in MKN45 cells, though their levels of expression were low. N. subflava adhered to MKN45 cells in vitro and colocalized with H. pylori in the human gastric mucosa.
CONCLUSIONS
Our data suggest that N. subflava colonized in the gastric mucosa contribute to gastric inflammation during chronic H. pylori gastritis.
TRANSLATIONAL IMPACT
NHGB may perpetuate gastric inflammation and accelerate neoplastic progression in the hypochlorhydric stomach.

Identifiants

pubmed: 30913125
doi: 10.14309/ctg.0000000000000024
pmc: PMC6445647
doi:

Substances chimiques

Interleukin-8 0
Lipopolysaccharide Receptors 0
Lipopolysaccharides 0
TLR2 protein, human 0
Toll-Like Receptor 2 0
Toll-Like Receptor 4 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00024

Références

N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
Lancet. 1991 Nov 9;338(8776):1175-6
pubmed: 1682595
Gut. 1992 Apr;33(4):429-31
pubmed: 1582581
Annu Rev Immunol. 2003;21:335-76
pubmed: 12524386
Infect Immun. 2012 Nov;80(11):4014-26
pubmed: 22949553
Gastroenterology. 2002 Jan;122(1):119-33
pubmed: 11781287
Gastroenterology. 2011 Jan;140(1):210-20
pubmed: 20950613
Sci Rep. 2016 Jul 14;6:29762
pubmed: 27412620
World J Gastroenterol. 2012 Mar 21;18(11):1257-61
pubmed: 22468090
Gut. 2015 Sep;64(9):1353-67
pubmed: 26187502
N Engl J Med. 1996 Jul 25;335(4):242-9
pubmed: 8657240
Infect Immun. 2010 Jan;78(1):468-76
pubmed: 19858308
Lancet. 2009 Oct 24;374(9699):1449-61
pubmed: 19683340
ISME J. 2011 Apr;5(4):574-9
pubmed: 20927139
Br Med J (Clin Res Ed). 1984 Sep 22;289(6447):717-9
pubmed: 6434053
Am J Pathol. 2016 Jun;186(6):1404-16
pubmed: 27083514
Aliment Pharmacol Ther. 2001 Aug;15(8):1163-75
pubmed: 11472319
J Med Microbiol. 1988 Apr;25(4):253-9
pubmed: 3357192
J Med Microbiol. 2000 Sep;49(9):817-822
pubmed: 10966230
FEMS Immunol Med Microbiol. 2007 Oct;51(1):140-8
pubmed: 17645528
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):732-7
pubmed: 16407106
Lancet. 1983 Jun 4;1(8336):1273-5
pubmed: 6134060
J Biol Chem. 2003 Aug 29;278(35):32552-60
pubmed: 12807870
J Gastroenterol. 2004;39(4):324-8
pubmed: 15168242
Helicobacter. 2014 Dec;19(6):407-16
pubmed: 25052961
Microbiology. 2012 Jun;158(Pt 6):1570-1580
pubmed: 22422752
Gut. 2014 Jan;63(1):54-63
pubmed: 23812323
Cancer Causes Control. 1993 Jul;4(4):297-305
pubmed: 8347778
Am J Gastroenterol. 2002 May;97(5):1106-12
pubmed: 12014714
Front Biosci. 2008 Jan 01;13:2400-7
pubmed: 17981721

Auteurs

Natsumi Miyata (N)

Division of Gastroenterology, Department of Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan.

Yoshikazu Hayashi (Y)

Division of Gastroenterology, Department of Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan.

Shunji Hayashi (S)

Division of Bacteriology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Japan.
Current affiliation: Department of Microbiology, Kitasato University School of Medicine, Kanagawa, Japan.

Kiichi Sato (K)

Division of Gastroenterology, Department of Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan.
Current affiliation: Department of Gastroenterology, International University of Health and Welfare, Tochigi, Japan.

Yoshikazu Hirai (Y)

Division of Bacteriology, Department of Infection and Immunity, School of Medicine, Jichi Medical University, Shimotsuke, Japan.
Current affiliation: Tamano Institute of Health and Human Services, Kake Educational Institution, Okayama, Japan.

Hironori Yamamoto (H)

Division of Gastroenterology, Department of Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan.

Kentaro Sugano (K)

Division of Gastroenterology, Department of Medicine, School of Medicine, Jichi Medical University, Tochigi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH